UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: March 21, 2018
Accession Number: 0001193125-18-076341
Submission Type: POS AM
CIK: 0001412067
Company Name: Cascadian Therapeutics, Inc.
File Number: 333-201317
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Cascadian Therapeutics, Inc. Charts.
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Cascadian Therapeutics, Inc. Charts.